Literature DB >> 29153267

How to eliminate HCV in people who inject drugs in the USA.

Harel Dahari1, Basmattee Boodram2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29153267      PMCID： PMC5951630          DOI： 10.1016/S1473-3099(17)30678-3

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  11 in total

1.  Residential transience and HIV risk behaviors among injection drug users.

Authors:  Danielle German; Melissa A Davey; Carl A Latkin
Journal:  AIDS Behav       Date:  2007-05-08

2.  Socio-behavioral and geographic correlates of prevalent hepatitis C virus infection among young injection drug users in metropolitan Baltimore and Chicago.

Authors:  Basmattee Boodram; Elizabeth T Golub; Lawrence J Ouellet
Journal:  Drug Alcohol Depend       Date:  2010-05-15       Impact factor: 4.492

3.  HCV kinetic and modeling analyses indicate similar time to cure among sofosbuvir combination regimens with daclatasvir, simeprevir or ledipasvir.

Authors:  Harel Dahari; Laetitia Canini; Frederik Graw; Susan L Uprichard; Evaldo S A Araújo; Guillaume Penaranda; Emilie Coquet; Laurent Chiche; Aurelie Riso; Christophe Renou; Marc Bourliere; Scott J Cotler; Philippe Halfon
Journal:  J Hepatol       Date:  2016-02-22       Impact factor: 25.083

4.  Direct-acting antivirals for acute HCV: how short can we go?

Authors:  Marianne Martinello; Jason Grebely; Gail V Matthews
Journal:  Lancet Gastroenterol Hepatol       Date:  2017-02-28

5.  Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012.

Authors:  Anil G Suryaprasad; Jianglan Z White; Fujie Xu; Beth-Ann Eichler; Janet Hamilton; Ami Patel; Shadia Bel Hamdounia; Daniel R Church; Kerri Barton; Chardé Fisher; Kathryn Macomber; Marisa Stanley; Sheila M Guilfoyle; Kristin Sweet; Stephen Liu; Kashif Iqbal; Rania Tohme; Umid Sharapov; Benjamin A Kupronis; John W Ward; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2014-08-11       Impact factor: 9.079

6.  High-Risk Geographic Mobility Patterns among Young Urban and Suburban Persons who Inject Drugs and their Injection Network Members.

Authors:  Basmattee Boodram; Anna L Hotton; Louis Shekhtman; Alexander Gutfraind; Harel Dahari
Journal:  J Urban Health       Date:  2018-02       Impact factor: 3.671

7.  The Impact of Enhanced Screening and Treatment on Hepatitis C in the United States.

Authors:  David P Durham; Laura A Skrip; Robert Douglas Bruce; Silvia Vilarinho; Elamin H Elbasha; Alison P Galvani; Jeffrey P Townsend
Journal:  Clin Infect Dis       Date:  2015-11-30       Impact factor: 9.079

8.  The impact of injecting networks on hepatitis C transmission and treatment in people who inject drugs.

Authors:  Margaret Hellard; David A Rolls; Rachel Sacks-Davis; Garry Robins; Philippa Pattison; Peter Higgs; Campbell Aitken; Emma McBryde
Journal:  Hepatology       Date:  2014-10-24       Impact factor: 17.425

9.  Hepatitis C virus treatment as prevention in an extended network of people who inject drugs in the USA: a modelling study.

Authors:  Alexei Zelenev; Jianghong Li; Alyona Mazhnaya; Sanjay Basu; Frederick L Altice
Journal:  Lancet Infect Dis       Date:  2017-11-15       Impact factor: 25.071

10.  Mathematical Modeling of Hepatitis C Prevalence Reduction with Antiviral Treatment Scale-Up in Persons Who Inject Drugs in Metropolitan Chicago.

Authors:  Desarae Echevarria; Alexander Gutfraind; Basmattee Boodram; Marian Major; Sara Del Valle; Scott J Cotler; Harel Dahari
Journal:  PLoS One       Date:  2015-08-21       Impact factor: 3.240
View more
  7 in total

1.  Modeling indicates efficient vaccine-based interventions for the elimination of hepatitis C virus among persons who inject drugs in metropolitan Chicago.

Authors:  Desarae Echevarria; Alexander Gutfraind; Basmattee Boodram; Jennifer Layden; Jonathan Ozik; Kimberly Page; Scott J Cotler; Marian Major; Harel Dahari
Journal:  Vaccine       Date:  2019-04-05       Impact factor: 3.641

2.  MULTI-OBJECTIVE MODEL EXPLORATION OF HEPATITIS C ELIMINATION IN AN AGENT-BASED MODEL OF PEOPLE WHO INJECT DRUGS.

Authors:  Eric Tatara; Nicholson T Collier; Jonathan Ozik; Alexander Gutfraind; Scott J Cotler; Harel Dahari; Marian Major; Basmattee Boodram
Journal:  Proc Winter Simul Conf       Date:  2020-02-20

3.  Modeling of patient virus titers suggests that availability of a vaccine could reduce hepatitis C virus transmission among injecting drug users.

Authors:  Marian Major; Alexander Gutfraind; Louis Shekhtman; Qingwen Cui; Alla Kachko; Scott J Cotler; Behzad Hajarizadeh; Rachel Sacks-Davis; Kimberly Page; Basmattee Boodram; Harel Dahari
Journal:  Sci Transl Med       Date:  2018-07-11       Impact factor: 17.956

Review 4.  Federal Response to the Opioid Crisis.

Authors:  Kimberly Johnson; Chris Jones; Wilson Compton; Grant Baldwin; Jennifer Fan; Jonathan Mermin; Jean Bennett
Journal:  Curr HIV/AIDS Rep       Date:  2018-08       Impact factor: 5.071

5.  People who inject drugs in metropolitan Chicago: A meta-analysis of data from 1997-2017 to inform interventions and computational modeling toward hepatitis C microelimination.

Authors:  Basmattee Boodram; Mary Ellen Mackesy-Amiti; Aditya Khanna; Bryan Brickman; Harel Dahari; Jonathan Ozik
Journal:  PLoS One       Date:  2022-01-12       Impact factor: 3.240

6.  Changing Urban-Rural Disparities in the Utilization of Direct-Acting Antiviral Agents for Hepatitis C in U.S. Medicare Patients, 2014-2017.

Authors:  Ping Du; Xi Wang; Lan Kong; Thomas Riley; Jeah Jung
Journal:  Am J Prev Med       Date:  2020-11-19       Impact factor: 5.043

7.  Modeling hepatitis C micro-elimination among people who inject drugs with direct-acting antivirals in metropolitan Chicago.

Authors:  Eric Tatara; Alexander Gutfraind; Nicholson T Collier; Desarae Echevarria; Scott J Cotler; Marian E Major; Jonathan Ozik; Harel Dahari; Basmattee Boodram
Journal:  PLoS One       Date:  2022-03-10       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.